Related Experiment Video

Updated: Jun 5, 2026

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
08:45

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance

Published on: December 28, 2017

Strategies to manage antifungal drug resistance

Hsiang-Kuang Tseng1, John R Perfect

  • 1Mackay Memorial Hospital, Division of Infectious Diseases, Department of Internal Medicine, Zhongshan Dist., Taipei, Taiwan.

Expert Opinion on Pharmacotherapy
|January 14, 2011
PubMed
Abstract

Insights

Antifungal drug resistance is a major challenge in treating invasive fungal infections, leading to poor outcomes. Understanding and addressing resistance mechanisms are crucial for successful patient management and improved survival rates.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Clinical Pharmacy

Background:

  • Invasive fungal infections (IFIs) pose a significant threat, causing high morbidity and mortality, particularly in immunocompromised individuals.
  • Despite available antifungal therapies, death rates from infections like cryptococcosis and candidiasis remain high, highlighting the urgent need for improved strategies.
  • Antifungal drug resistance (AFDR) is a growing concern, necessitating a deeper understanding of its mechanisms and clinical implications.

Purpose of the Study:

  • To review the multifaceted issues surrounding antifungal drug resistance in the context of invasive fungal infections.
  • To provide clinicians with insights into the complexities of managing IFIs in at-risk populations.
  • To identify current limitations in antifungal treatment and guide the development of enhanced therapeutic strategies.

Main Methods:

  • A comprehensive review of existing literature on antifungal drug resistance and its clinical impact.
  • Analysis of detection methods for antifungal resistance.
  • Examination of strategies to prevent treatment failures and manage IFIs.

Main Results:

  • Antifungal drug resistance presents both direct and clinical challenges in managing IFIs.
  • Understanding resistance mechanisms is key to successful treatment outcomes.
  • Current antifungal drugs can be effective if resistance issues are properly addressed and underlying diseases are controlled.

Conclusions:

  • Invasive fungal infections are serious, life-threatening conditions requiring careful management.
  • Addressing antifungal drug resistance is paramount to reducing therapeutic failures.
  • Effective management of IFIs relies on controlling underlying diseases and optimizing antifungal therapy based on resistance patterns.

More Related Videos

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...